{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:43:41Z","timestamp":1774428221952,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.pathophys.2011.09.001","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T06:31:23Z","timestamp":1316759483000},"page":"29-34","source":"Crossref","is-referenced-by-count":16,"title":["Combined estrogen\u2013progestogen but not progestogen-only oral contraceptive alters glucose tolerance and plasma lipid profile in female rats"],"prefix":"10.1016","volume":"19","author":[{"given":"L.A.","family":"Olatunji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.S.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.O.","family":"Adewumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.J.","family":"Aiyegboyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.A.","family":"Olatunji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2011.09.001_bib0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ecl.2005.04.012","article-title":"Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents","volume":"34","author":"Hillard","year":"2005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2265.1994.tb02476.x","article-title":"Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives","volume":"40","author":"Sheu","year":"1994","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0015","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/07853899509031958","article-title":"Influence of oral contraceptive use on lipoprotein(a) and other coronary heart disease risk factors","volume":"27","author":"Porkka","year":"1995","journal-title":"Ann. Med."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0020","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1210\/jc.82.9.3074","article-title":"The effect of a desogestrelcontaining oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women","volume":"82","author":"Nader","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004872-199816030-00013","article-title":"A study of interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity, and glucose tolerance in normotensive women","volume":"16","author":"Straznicky","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0030","first-page":"2073","article-title":"Update on oral contraceptive pills","volume":"60","author":"Cerel-Suhl","year":"1999","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(79)92949-0","article-title":"Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism","volume":"1","author":"Wynn","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0040","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.80.11.3327","article-title":"Metabolic effects of oral contraceptives in women with polycystic ovary syndrome","volume":"80","author":"Korytkowski","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0045","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case\u2013control study","volume":"349","year":"1997","journal-title":"The Lancet"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/17455057.1.1.133","article-title":"Oral contraceptives and cardiovascular disease: emerging evidence on potential associations with angina, myocardial infarction and stroke","volume":"1","author":"Victory","year":"2005","journal-title":"Women's Health"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0055","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0060","first-page":"33","article-title":"Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial","volume":"71","author":"Burkman","year":"1988","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0065","first-page":"892","article-title":"Effects of oral contraceptives on carbohydrate metabolism","volume":"31","author":"Wynn","year":"1986","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1210\/jc.74.1.64","article-title":"Insulin resistance, secretion, and metabolism in users of oral contraceptives","volume":"74","author":"Godsland","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/0002-9378(87)90355-3","article-title":"Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism","volume":"156","author":"van der Vange","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0085","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/0002-9378(89)90704-7","article-title":"Triphasic Randomized Clinical Trial: comparison of effects on carbohydrate metabolism","volume":"161","author":"Bowes","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0090","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/0002-9378(88)90194-9","article-title":"Lipids, clothing factors, and diabetes: endogenous risk factors for cardiovascular disease","volume":"158","author":"Lobo","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0002-9378(90)90578-U","article-title":"Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism and development of cardiovascular disease","volume":"63","author":"Gaspard","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0105","first-page":"155","article-title":"Effect of increased magnesium intake on plasma cholesterol, triglyceride and oxidative stress in alloxan-diabetic rats","volume":"36","author":"Olatunji","year":"2007","journal-title":"Afr. J. Med. Sci."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pathophys.2006.09.004","article-title":"Increased magnesium intake prevents hyperlipidemia and insulin resistance and reduces lipid peroxidation in fructose-fed rats","volume":"14","author":"Olatunji","year":"2007","journal-title":"Pathophysiology"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ajcn\/30.3.381","article-title":"The effects of an oral contraceptive on plasma growth hormone and glucose tolerance in two strains of rats","volume":"30","author":"Arnold","year":"1977","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0125","first-page":"71","article-title":"Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus","volume":"18","author":"Harvengt","year":"1992","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0130","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1210\/jc.2007-2599","article-title":"Effect of low-dose oral contraceptives on metabolic risk factors in African-American women","volume":"93","author":"Frempong","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0135","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1210\/jc.2003-030029","article-title":"Effects of long-term estrogen replacement therapy versus combined hormone replacement therapy on nitric oxide-dependent vasomotor function","volume":"88","author":"Jokela","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0140","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.21.10.1589","article-title":"Effect of postmenopausal hormone therapy on glucose and insulin concentrations: PEPI Investigators: Postmenopausal Estrogen\/Progestin Interventions","volume":"21","author":"Espeland","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diacare.25.3.500","article-title":"The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in American Indian postmenopausal women","volume":"25","author":"Zhang","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/1047-2797(92)90011-E","article-title":"A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus","volume":"2","author":"Manson","year":"1992","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2105\/AJPH.87.3.443","article-title":"The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus","volume":"87","author":"Gabal","year":"1997","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria","volume":"161","author":"DECODE Study Group, the European Diabetes Epidemiology Group","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0170","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2337\/db06-0577","article-title":"Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes","volume":"55","author":"van Genugten","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/dmr.5610080402","article-title":"Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM)","volume":"8","author":"Hamman","year":"1992","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0180","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1210\/jc.79.5.1277","article-title":"Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors","volume":"79","author":"Watanabe","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 738","key":"10.1016\/j.pathophys.2011.09.001_bib0185","first-page":"1","article-title":"The influence of female sex steroids on glucose metabolism and insulin action","volume":"240","author":"Godsland","year":"1996","journal-title":"J. Int. Med."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jcem-52-1-29","article-title":"Changes in insulin receptors during oral contraception","volume":"52","author":"De Pirro","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/jcem-50-2-246","article-title":"Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle","volume":"50","author":"Bertoli","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0200","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0378-5122(89)90216-8","article-title":"Carbohydrate metabolism during hormone substitution therapy","volume":"11","author":"DeCleyn","year":"1989","journal-title":"Maturitas"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0205","first-page":"1","article-title":"Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetic risk","volume":"86","author":"Godsland","year":"1996","journal-title":"Br. J. Clin. Pract. Suppl."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0210","doi-asserted-by":"crossref","first-page":"29E","DOI":"10.1016\/S0002-9149(02)03386-6","article-title":"Treatment for patients with metabolic syndrome","volume":"91","author":"Ginsberg","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pathophys.2011.09.001_bib0215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein (a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"104","author":"Sharrett","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0220","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2011.09.001_bib0225","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0889-8529(18)30250-0","article-title":"Update on the metabolic effects of steroidal contraceptives","volume":"20","author":"Sondheimer","year":"1991","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"4 Pt 2","key":"10.1016\/j.pathophys.2011.09.001_bib0230","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0002-9378(12)90408-1","article-title":"The metabolic impact of oral contraceptives","volume":"167","author":"Krauss","year":"1992","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468011000514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468011000514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T15:49:32Z","timestamp":1593013772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468011000514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0928468011000514"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2011.09.001","relation":{},"ISSN":["0928-4680"],"issn-type":[{"value":"0928-4680","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}